Drag

Indo US Bio-Tech

Basic Materials NSE:INDOUS

113.42INR
-24.68 ( -17.87%)

Last update at March 6, 2026, midnight

Day Range

110.48140.86
LowHigh

52 Week Range

109.50 257.60
LowHigh

Fundamentals

  • Previous Close 138.10
  • Market Cap 2604.44M
  • Volume326,987
  • P/E Ratio 14.49
  • EBITDA 209.44M
  • Revenue TTM 1098.90M
  • Revenue Per Share TTM 54.88
  • Gross Profit TTM 331.66M
  • Diluted EPS TTM 8.90

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED PIIND ₹ 3949.80 4/06/25 17/06/25 13 Days Short Term Basic Materials 6.28%

Financials

No income statement data available.

No balance sheet data available.

No cash flow data available.

Peer Comparison

Sector: Basic Materials Industry: Agricultural Inputs

Company Change Price Market Cap (M) P/E Ratio
INDOUS
Indo US Bio-Tech
-24.68 -17.87% 113.42 2604.44 14.49
UPL
UPL Limited
-1.25 -0.20% 628.35 670902.52 30.63
COROMANDEL
Coromandel International Limited
-41.20 -2.00% 2022.30 670824.20 27.92
FACT
Fertilizers and Chemicals Travancore Limited
2.60 0.38% 680.65 576638.22 567.61
PIIND
PI Industries Limited
-9.40 -0.30% 3079.60 492352.83 32.51

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.